Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Efficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation) Proceeding/Conference:European Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt) | 10-Jun-2023 |